OSL 0.00% 0.6¢ oncosil medical ltd

Ann: Positive PanCO trial update on resected cohort, page-2

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    So according to OSL release , the survival data are in line with what would be expected with neoadjuvant chemotherapy.
    - but in Panco trial these patients received neoadjuvant chemo plus oncosil device
    - so isn’t this just saying if results are in line with neoadjuvant chemo as OSL state, the device doesn’t add any further benefit over what you’d expect with chemo??
    - they should really present the median survival for all 10
    - to me these results are ok, and obviously good for the 6 who’ve made it this far- but overall not stand-out
    - why haven’t they provided updated survival for the whole study?
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $19.99M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $7.102K 1.28M

Buyers (Bids)

No. Vol. Price($)
9 3863512 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20657288 25
View Market Depth
Last trade - 13.37pm 04/07/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.